INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 289 filers reported holding INTELLIA THERAPEUTICS INC in Q2 2024. The put-call ratio across all filers is 1.27 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $245,128 | -18.8% | 10,953 | -0.2% | 0.04% | -22.6% |
| Q1 2024 | $301,950 | -25.1% | 10,976 | -17.0% | 0.05% | -32.9% |
| Q4 2023 | $403,017 | -3.6% | 13,218 | +0.0% | 0.08% | -16.8% |
| Q3 2023 | $417,890 | -23.0% | 13,216 | -0.7% | 0.10% | -22.1% |
| Q2 2023 | $542,904 | +8.8% | 13,313 | -0.6% | 0.12% | 0.0% |
| Q1 2023 | $499,157 | +7.0% | 13,393 | +0.1% | 0.12% | -8.3% |
| Q4 2022 | $466,584 | -36.9% | 13,373 | +1.1% | 0.13% | -50.2% |
| Q3 2022 | $740,000 | +8.2% | 13,224 | +0.1% | 0.27% | +4.7% |
| Q2 2022 | $684,000 | -17.8% | 13,208 | +0.0% | 0.26% | -6.6% |
| Q1 2022 | $832,000 | – | 13,206 | – | 0.27% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 1,216,340 | $62,958,000 | 7.04% |
| Discovery Value Fund | 584,483 | $30,253,000 | 6.33% |
| MPM BioImpact LLC | 299,409 | $15,497,000 | 4.30% |
| ARK Investment Management | 9,514,580 | $439,003,000 | 2.60% |
| Elmwood Wealth Management, Inc. | 67,899 | $3,514,000 | 2.00% |
| Nikko Asset Management Americas, Inc. | 2,781,136 | $141,143,000 | 1.74% |
| Avidity Partners Management LP | 1,125,194 | $58,240,000 | 1.34% |
| Merlin Capital, Inc | 12,174 | $630,000 | 1.26% |
| Atlas Venture Associates IX, LLC | 10,000 | $518,000 | 1.18% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 111,440 | $5,768,000 | 1.16% |